Project: Bioavailability models for innovative ecological risk assessment of pharmaceuticals (ECOPHARMA)
2019-10-01 – 2024-07-30
- Abstract
Human pharmaceuticals are increasingly detected in waterways. Yet, the estimation of their ecological risks may be more than 10-fold wrong, because bioavailability is completely ignored. ECOPHARMA will develop bioavailability models to calculate how physicochemical water characteristics affect pharmaceutical uptake, ecotoxicity to organisms and risks. These models will innovate pharmaceutical risk assessment, contribute to sustainable pharma-industry and improve water quality management.
Show
Sort by
-
Mapping the risk of ciprofloxacin in European water bodies : incorporating the impact of bioavailability
-
Mixture toxicity of the heavy metal copper and the fluoroquinolone antibiotic ciprofloxacin on Microcystis aeruginosa
-
Bioavailability models for innovative ecological risk assessment of antibiotics
(2024) -
- Journal Article
- A1
- open access
The influence of pH and dissolved organic carbon on the ecotoxicity of ampicillin and clarithromycin
-
- Journal Article
- A1
- open access
Water brownness regulates the bioavailability of a fluoroquinolone antibiotic : UV-absorbance as a predictor of ciprofloxacin ecotoxicity
-
- Journal Article
- A1
- open access
A bioavailability model to predict the impact of pH and dissolved organic carbon on ciprofloxacin ecotoxicity to the cyanobacterium Microcystis aeruginosa